Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Nonrandom chromosomal aberrations are crucial in cancer, revealing disease pathways and serving as diagnostic/prognostic markers.
• In situ hybridization methods are key for identifying numerical and structural chromosome abnormalities.

Purpose of the Study:

• To develop novel, unique-sequence in situ hybridization probes with enhanced features for detecting chromosomal aberrations.
• To demonstrate the utility of these probes in identifying oncogene regions and chromosomal translocations in cancer.

Main Methods:

• Probes constructed from multimegabase yeast artificial chromosome (YAC) contigs.
• Probes are short-fragment DNA libraries, amplified via polymerase chain reaction (PCR).
• Repetitive sequences removed by subtractive hybridization, creating "subtracted probes".

Main Results:

• Subtracted probes offer convenient labeling and extremely bright fluorescence/colorimetric signals.
• Probes are stable and amplify through at least four PCR rounds without signal loss.
• Demonstrated applications include characterizing EWS-region translocations in Ewing's sarcoma and detecting translocations in paraffin sections and via bright-field microscopy.

Conclusions:

• The developed subtracted probes represent a significant advancement in in situ hybridization technology.
• These probes provide a robust and sensitive tool for identifying chromosomal aberrations in cancer research and diagnostics.
• Applications range from basic research to clinical pathology, improving translocation detection.